Business Context and Reporting Period
This Form 8-K Current Report was filed by The Clorox Company on March 7, 2006. The filing addresses a significant change in corporate leadership triggered by the hospitalization of Chairman and Chief Executive Officer Jerry Johnston.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
- Leadership Transition: Robert W. Matschullat was appointed as interim Chairman and interim Chief Executive Officer, effective immediately.
- Board Committee Adjustments: Mr. Matschullat stepped down as presiding director, audit committee member, and chair of the nominating and governance committee.
- Interim Appointments: Gary G. Michael was appointed interim presiding director, and Daniel Boggan, Jr. was appointed interim chair of the nominating and governance committee.
Outlook, Risks, and Unusual Items
Employment Terms: The terms of Mr. Matschullat's interim employment arrangement have not been determined at the time of filing. The Company indicated it will file an amendment to this Form 8-K once these terms are established.
Unusual Item: The immediate cause for the leadership change is the hospitalization of the sitting CEO, Jerry Johnston.
Investor Verification Checklist
- Verify the current health status and expected return timeline for CEO Jerry Johnston.
- Monitor for the upcoming Form 8-K amendment detailing Mr. Matschullat's interim compensation and employment terms.
- Confirm the duration of the interim leadership arrangement and any plans for a permanent CEO search.